Abstract
Recent years has seen the rapid growth and scale of Counterfeit Pharmaceuticals in Nigeria irrespective of the Intellectual Property Right (IPR) standard provided by the World Trade Organisation-Trade Related aspect of Intellectual Property Right (WTO-TRIPS) Agreement. The effect of the WTO-TRIPS protection of Intellectual Property Rights creates the problem of access to medicine for developing countries. This has provoked counterfeit pharmaceutical activities worldwide and prevalently in Nigeria. The aim is to ascertain, by way of analytical framework the viability of the WTO-TRIPS agreement for addressing the scourge of counterfeit pharmaceuticals in Nigeria. The concept of counterfeit pharmaceuticals will be explored, and its parameters defined as a premise for testing the viability of the WTO-TRIPS and the Nigerian Counterfeit regulatory framework.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Public and Private Perspectives on Healthcare, Culture, and the Environment
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
